Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.01
-0.0600-1.47%
Post-market: 3.99-0.0200-0.50%19:30 EDT
Volume:1.65M
Turnover:6.64M
Market Cap:386.13M
PE:-5.37
High:4.20
Open:4.13
Low:3.97
Close:4.07
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:1.05
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7467
EPS(LYR):-0.7467
ROE:-59.04%
ROA:-35.32%
PB:3.83
PE(LYR):-5.37

Loading ...

Rezolute Price Target Announced at $9.00/Share by Lake Street

Dow Jones
·
Oct 01

Rezolute Raised to Buy from Hold by Craig-Hallum

Dow Jones
·
Sep 29

Craig-Hallum Upgrades Rezolute to Buy From Hold, Price Target is $7

MT Newswires Live
·
Sep 29

Rezolute upgraded to Buy from Hold at Craig-Hallum

TIPRANKS
·
Sep 29

Rezolute price target raised to $10 from $6 at Jones

TIPRANKS
·
Sep 29

Rezolute, Inc. : H.c. Wainwright Raises Target Price to $10

THOMSON REUTERS
·
Sep 28

Rezolute is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 26

Douglas Tsao Boosts RZLT Price Target to $10 and Reiterates Buy on Strong upLIFT Clinical Momentum

TIPRANKS
·
Sep 25

Rezolute price target raised to $10 from $5 at H.C. Wainwright

TIPRANKS
·
Sep 25

Rezolute Fiscal Q4 Loss Narrows

MT Newswires Live
·
Sep 25

Rezolute Q4 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Sep 25

Rezolute Q4 EPS $(0.20) Misses $(0.15) Estimate

Benzinga Earnings
·
Sep 25

Rezolute FY26 Net Loss Widens 4.26% to $77.59 Million; FY26 G&A Expenses Climb 58.79% to $29.17 Million

Reuters
·
Sep 25

Rezolute Q4 EPS USD -0.2

Reuters
·
Sep 25

Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Sep 25

Rezolute Q4 Operating Expenses USD 21.562 Million

THOMSON REUTERS
·
Sep 25

Top News Today/Canada: Inflation Holds Steady at 3%

Dow Jones
·
Sep 15

Rezolute, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Sep 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 10

Rezolute Says FDA Review Continues for Phase 3 sunRIZE Data on Ersodetug in Congenital Hyperinsulinism

Reuters
·
Sep 09